How to Maintain Velocity Without Sacrificing Quality

Interview with Qualio Founder and CEO Robert Fenton

Fast, good, or cheap — you can only pick two, so which will it be? It’s a common question, but it’s probably not one that’s best suited for the medtech and healthtech industries.

For many, quality is viewed as a hurdle, slowing a project’s velocity, but Robert Fenton founder and CEO at Qualio is determined to change that reality for companies developing life-saving products.

While working in drug development for some of the world’s largest pharmaceutical companies, including Pfizer and LEO Pharma, Robert observed how an organization moves an idea from bench science to proof of concept and beyond.

“What really struck me is that companies make a clinical promise: First, do no harm,” he says. “If you’re working on a medical device that’s going to diagnose or treat something really important, it must be safe, it must work effectively, and it must work consistently, which is, essentially, the promise of quality.”

Robert set out to develop a cloud-based quality management system that would help life sciences companies launch and scale their life-saving products without sacrificing quality or slowing down the multistage process.

In this episode of Medsider, Robert shares his predictions for the life sciences industry in 2022. He also discusses how Qualio can support (and not hinder) medtech and healthtech companies as they move through the complex process of taking a product from conception to the market.

Premium Members Only

Premium Members Only

You don't have access to this post, but if you become a premium member, you'll be able to see the whole thing, including many other exclusive benefits.

You don't have access to this post, but if you become a premium member, you'll be able to see the whole thing, including many other exclusive benefits.

You May Like These Articles

Medsider Premium

Become a premium member and unlock access to exclusive Medsider benefits.

Medsider Mentors

Medsider Mentors

Medsider Playbooks

Medsider Playbooks

Playbook

A Guide to Widespread Adoption in Medtech

In medtech, developing novel, impactful technology is often just the starting line. The real race begins when you try to integrate your solution into the often-resistant healthcare system – a hurdle that has tripped up countless promising companies. Here are the key strategies and lessons from five veterans in the medtech space on how to overcome this hurdle.

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest